Skip to content

Source filing unavailable

Q4 2011 · —
Revenue$203.52M+4.8% vs Q4 2010+0.7% vs Q3 2011
Net Income$4.56M−75.8% vs Q4 2010−59.4% vs Q3 2011
EPS Diluted$0.16−74.6% vs Q4 2010−59.0% vs Q3 2011
Gross Profit$120,783,000−1.7%
Operating Incomederived$7,749,000−67.9%
Operating Cash Flowderived$34,695,000+22.0%
Free Cash Flowderived$21,651,000+112.5%
Margins · derived
Gross margin59.3%−3.9 pt vs Q4 2010
Operating margin3.8%−8.6 pt vs Q4 2010
Net margin2.2%−7.4 pt vs Q4 2010

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ4 2011Q4 2010Q4 2009derived from reported figures
Revenue$203.52M$194.13M—
Net Income$4.56M$18.81M—
EPS Diluted$0.16$0.63—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR